SILVERARC CAPITAL MANAGEMENT, LLC Quant / Systematic

Location: Boston, MA

CIK: 0001816307 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Jul 25, 2022

Total Value: $325M (100.0% shares, 0.0% debt)

Holdings (70)

QQQ INVESCO QQQ TR 14.0%
Value $45.55M Shares 162,500 Est. Cost Unrealized
INTRA-CELLULAR THERAPIES INC 5.5%
Value $17.92M Shares 313,962 Est. Cost $48.96 Unrealized
XBI SPDR SER TR 4.8%
Value $15.47M Shares 208,300 Est. Cost Unrealized
BELLUS HEALTH INC NEW 4.4%
Value $14.44M Shares 1,562,957 Est. Cost $6.76 Unrealized
VCYT VERACYTE INC 4.4%
Value $14.3M Shares 718,789 Est. Cost $30.89 Unrealized -34.6%
CERS CERUS CORP 3.4%
Value $11.08M Shares 2,093,861 Est. Cost $5.69 Unrealized -12.2%
MERUS N V 3.3%
Value $10.62M Shares 469,113 Est. Cost $21.56 Unrealized
AVXL ANAVEX LIFE SCIENCES CORP 2.8%
Value $9.18M Shares 917,100 Est. Cost Unrealized
MORPHIC HLDG INC 2.8%
Value $9.085M Shares 418,660 Est. Cost $25.71 Unrealized
VERU INC 2.7%
Value $8.819M Shares 780,400 Est. Cost Unrealized
PROMETHEUS BIOSCIENCES INC 2.6%
Value $8.517M Shares 301,700 Est. Cost Unrealized
CTI BIOPHARMA CORP 2.5%
Value $8.239M Shares 1,380,111 Est. Cost $3.23 Unrealized
ACRS ACLARIS THERAPEUTICS INC 2.3%
Value $7.532M Shares 539,545 Est. Cost $15.96 Unrealized -12.2%
COGT COGENT BIOSCIENCES INC 2.3%
Value $7.405M Shares 820,954 Est. Cost $7.94 Unrealized -14.0%
SEAGEN INC 2.2%
Value $7.217M Shares 40,787 Est. Cost $175.43 Unrealized
XENE XENON PHARMACEUTICALS INC 2.2%
Value $7.077M Shares 232,630 Est. Cost $29.04 Unrealized +4.1%
KRYS KRYSTAL BIOTECH INC 2.1%
Value $6.912M Shares 105,277 Est. Cost $60.44 Unrealized +2.9%
MIRATI THERAPEUTICS INC 2.1%
Value $6.773M Shares 100,900 Est. Cost $164.76 Unrealized
APLS APELLIS PHARMACEUTICALS INC 1.8%
Value $5.869M Shares 129,795 Est. Cost $44.42 Unrealized +2.6%
ALNY ALNYLAM PHARMACEUTICALS INC 1.8%
Value $5.834M Shares 40,000 Est. Cost Unrealized
HORIZON THERAPEUTICS PUB L 1.8%
Value $5.758M Shares 72,187 Est. Cost $87.07 Unrealized
ORIC ORIC PHARMACEUTICALS INC 1.5%
Value $4.849M Shares 1,082,304 Est. Cost $3.99 Unrealized 0.0%
CONTRAFECT CORP 1.5%
Value $4.798M Shares 1,562,900 Est. Cost Unrealized
BIIB BIOGEN INC 1.3%
Value $4.247M Shares 20,825 Est. Cost $236.67 Unrealized -13.6%
INSM INSMED INC 1.3%
Value $4.19M Shares 212,482 Est. Cost $28.41 Unrealized -26.2%
IVERIC BIO INC 1.3%
Value $4.145M Shares 430,900 Est. Cost Unrealized
MERSANA THERAPEUTICS INC 1.2%
Value $3.927M Shares 850,000 Est. Cost $4.62 Unrealized
APOLLO ENDOSURGERY INC 1.2%
Value $3.923M Shares 1,074,879 Est. Cost $7.53 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 1.2%
Value $3.843M Shares 26,374 Est. Cost $83.53 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 1.2%
Value $3.824M Shares 16,227 Est. Cost $179.74 Unrealized +13.1%
IMTX IMMATICS N.V 1.0%
Value $3.093M Shares 355,103 Est. Cost $11.68 Unrealized -32.3%
VRTX VERTEX PHARMACEUTICALS INC 0.9%
Value $2.935M Shares 10,414 Est. Cost $224.83 Unrealized +19.0%
CGEM CULLINAN ONCOLOGY INC 0.8%
Value $2.732M Shares 213,090 Est. Cost $11.34 Unrealized 0.0%
CRNX CRINETICS PHARMACEUTICALS IN 0.8%
Value $2.602M Shares 139,539 Est. Cost $22.40 Unrealized -10.9%
RGNX REGENXBIO INC 0.8%
Value $2.572M Shares 104,129 Est. Cost $24.98 Unrealized 0.0%
AKERO THERAPEUTICS INC 0.8%
Value $2.46M Shares 260,325 Est. Cost $9.45 Unrealized
MIRATI THERAPEUTICS INC 0.8%
Value $2.444M Shares 36,403 Est. Cost $164.76 Unrealized
OTONOMY INC 0.7%
Value $2.166M Shares 1,041,273 Est. Cost $3.08 Unrealized
CLYM ELIEM THERAPEUTICS INC 0.7%
Value $2.153M Shares 713,009 Est. Cost $5.30 Unrealized -10.7%
SNDX SYNDAX PHARMACEUTICALS INC 0.6%
Value $2.075M Shares 107,852 Est. Cost $18.35 Unrealized -9.2%
PHR PHREESIA INC 0.6%
Value $1.954M Shares 78,111 Est. Cost $22.02 Unrealized 0.0%
VRAYQ VIEWRAY INC 0.6%
Value $1.942M Shares 732,740 Est. Cost $4.75 Unrealized -36.7%
DAWN DAY ONE BIOPHARMACEUTICALS I 0.6%
Value $1.888M Shares 105,476 Est. Cost $10.33 Unrealized 0.0%
IMMUNOGEN INC 0.6%
Value $1.874M Shares 416,479 Est. Cost $7.12 Unrealized
CVRX CVRX INC 0.5%
Value $1.756M Shares 292,145 Est. Cost $5.75 Unrealized 0.0%
EYPT EYEPOINT PHARMACEUTICALS INC 0.5%
Value $1.555M Shares 197,640 Est. Cost $11.76 Unrealized -14.5%
CDXS CODEXIS INC 0.4%
Value $1.443M Shares 137,960 Est. Cost $17.34 Unrealized -27.7%
HUMANIGEN INC 0.4%
Value $1.383M Shares 781,100 Est. Cost Unrealized
NKTX NKARTA INC 0.4%
Value $1.365M Shares 110,763 Est. Cost $13.12 Unrealized 0.0%
AMRYT PHARMA PLC 0.4%
Value $1.232M Shares 176,309 Est. Cost $12.91 Unrealized
SERES THERAPEUTICS INC 0.4%
Value $1.193M Shares 347,761 Est. Cost $9.62 Unrealized
NGM BIOPHARMACEUTICALS INC 0.3%
Value $1.132M Shares 88,303 Est. Cost $15.25 Unrealized
ZYMEWORKS INC 0.3%
Value $1.104M Shares 208,330 Est. Cost $5.30 Unrealized
POSEIDA THERAPEUTICS INC 0.3%
Value $982K Shares 380,606 Est. Cost $5.22 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 0.3%
Value $979K Shares 36,322 Est. Cost $42.13 Unrealized -31.1%
CLDX CELLDEX THERAPEUTICS INC NEW 0.3%
Value $971K Shares 36,000 Est. Cost $42.13 Unrealized -31.1%
SPRY SILVERBACK THERAPEUTICS INC 0.3%
Value $887K Shares 209,108 Est. Cost $3.49 Unrealized 0.0%
POLYPID LTD 0.2%
Value $750K Shares 161,572 Est. Cost $8.42 Unrealized
STXS STEREOTAXIS INC 0.2%
Value $678K Shares 368,648 Est. Cost $7.28 Unrealized -67.2%
FORMA THERAPEUTICS HLDGS INC 0.2%
Value $650K Shares 94,386 Est. Cost $9.30 Unrealized
CHEMOCENTRYX INC 0.2%
Value $645K Shares 26,036 Est. Cost $24.77 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC 0.2%
Value $566K Shares 53,521 Est. Cost $16.04 Unrealized -35.7%
MGTX MEIRAGTX HLDGS PLC 0.1%
Value $394K Shares 52,066 Est. Cost $9.70 Unrealized 0.0%
ELOXX PHARMACEUTICALS INC 0.1%
Value $281K Shares 1,041,499 Est. Cost $1.53 Unrealized
CGEN COMPUGEN LTD 0.1%
Value $193K Shares 104,150 Est. Cost $7.48 Unrealized -71.1%
MREO MEREO BIOPHARMA GROUP PLC 0.1%
Value $175K Shares 156,195 Est. Cost $3.32 Unrealized
EVOGENE LTD 0.0%
Value $156K Shares 202,322 Est. Cost $4.20 Unrealized
ALIGOS THERAPEUTICS INC 0.0%
Value $71,000 Shares 58,392 Est. Cost $1.39 Unrealized
MEDICUS SCIENCES ACQUISITION 0.0%
Value $9,000 Shares 49,990 Est. Cost $1.00 Unrealized
RENOVACOR INC 0.0%
Value $6,000 Shares 104,828 Est. Cost $0.40 Unrealized